AstraZeneca slips after FDA panel rejects breast cancer drug camizestrant

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Form 6K AstraZeneca PLC ADR For: 21 April Hisse Senetleri 0 6
A AstraZeneca’s Ultomiris meets trial goal for kidney disease Hisse Senetleri 0 4
A TD Cowen reiterates Buy on AstraZeneca stock after COPD trial Hisse Senetleri 0 14
A AstraZeneca’s tozorakimab meets COPD trial endpoints Hisse Senetleri 0 9
A AstraZeneca wins EU approval for Imfinzi in early gastric cancer Hisse Senetleri 0 13
A FTSE 100 today: Index slips as BP halts buyback; AstraZeneca, Barclays in focus Hisse Senetleri 0 26
A Citi initiates coverage of European pharma stocks; AstraZeneca ‘best in class’ Hisse Senetleri 0 21
A AstraZeneca reports total voting rights of 1.55 billion shares Hisse Senetleri 0 22

Benzer konular

Üst